Sign in
Taking people in CzechiaPhase 3

Tests higher vitamin D doses for bone strength in children with cystic fibrosis

Compares 6000 and 1000 IU vitamin D daily in children with cystic fibrosis.

Key facts

Who runs it
Fakultni Nemocnice V Motole
Where
Prague, CzechiaSee the site
Registry title
The randomized, double blind study phase III.b of the Comprehensive assessment of the musculoskeletal health in children with cystic fibrosis – on the search for means of improvement
Status
Recruiting
Phase
Phase 3
People taking part
64 people, planned
Started
2 Oct 2024
Expected to end
1 Jan 2027
Type of study
Interventional
Record updated
2 October 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children with cystic fibrosis. It compares two daily doses of vitamin D (cholecalciferol) over two years to see the effect on bones and muscle strength.

Age
6 to 16 years (included)
Sex
Boys and girls can both join.
Disease stage
A diagnosis of cystic fibrosis is needed. No stage or severity is stated.
Earlier treatment
Children cannot join if they had bisphosphonate treatment in the last 18 months.

Main reasons for not taking part

  • Lung transplantation, done or planned
  • Bisphosphonate treatment in the last 18 months
  • Another disease besides cystic fibrosis that is known to affect bone metabolism
  • Hypercalcaemia
  • Pregnancy

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Diagnosis of cystic fibrosis
  • Age from 6 to 16 (included) years
  • Willingness of the parent or legal representative to sign the informed consent and allow the child participate in the study
  • Woman of childbearing potential need to comply with adequate contraception methods per CTFG guideline

Who cannot take part

  • Lung transplantation (done or planned)
  • Disease other than CF with known impact on bone metabolism (based on consultancy with main investigator)
  • Hypersensitivity to the IMP or additive substance (as per SmPC)
  • Contraindication done by SmPC of Vigantol
  • Bisphosphonate treatment in the last 18 months
  • Hypercalcaemia
  • Renal osteodystrophy with hyperphosphatemia
  • Pregnancy

Where in Czechia

  • Fakultni nemocnice v MotolePrague, CzechiaTaking people

About the trial

What the trial wants to find out

The goal of this study is to assess whether 6000 IU of cholecalciferol per day given over two years to children with cystic fibrosis is superior to 1000 IU of cholecalciferol in normalizing their bone metabolism parameters and in improving their bone density and skeletal muscle force.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
The randomized, double blind study phase III.b of the Comprehensive assessment of the musculoskeletal health in children with cystic fibrosis – on the search for means of improvement
Plain-language title
Tests higher vitamin D doses for bone strength in children with cystic fibrosisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
2 October 2024